These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 9316472)

  • 21. CCK antagonists reveal that CCK-8 and JMV-180 interact with different sites on the rat pancreatic acinar cell CCKA receptor.
    Yule DI; Williams JA
    Peptides; 1994; 15(6):1045-51. PubMed ID: 7527529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into neurohormonal regulation of pancreatic secretion.
    Owyang C; Logsdon CD
    Gastroenterology; 2004 Sep; 127(3):957-69. PubMed ID: 15362050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
    Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD
    Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microinjection of exogenous somatostatin in the dorsal vagal complex inhibits pancreatic secretion via somatostatin receptor-2 in rats.
    Liao Z; Li ZS; Lu Y; Wang WZ
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G746-52. PubMed ID: 17138968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat.
    Brzozowski T; Konturek PC; Konturek SJ; Kwiecién S; Pajdo R; Brzozowska I; Hahn EG
    J Clin Gastroenterol; 1998; 27 Suppl 1():S125-37. PubMed ID: 9872509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
    Garlicki J; Konturek PK; Majka J; Kwiecien N; Konturek SJ
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E40-5. PubMed ID: 2301570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid.
    Mönnikes H; Lauer G; Bauer C; Tebbe J; Zittel TT; Arnold R
    Am J Physiol; 1997 Dec; 273(6):R2059-71. PubMed ID: 9435662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
    Wan S; Coleman FH; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats.
    Lloyd KC; Raybould HE; Walsh JH
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G287-92. PubMed ID: 1357976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats.
    Reidelberger RD
    Am J Physiol; 1992 Dec; 263(6 Pt 2):R1354-8. PubMed ID: 1481948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of pancreatic growth by cholecystokinin is mediated by high affinity receptors on rat pancreatic acinar cells.
    Dawra R; Saluja A; Lerch MM; Saluja M; Logsdon C; Steer M
    Biochem Biophys Res Commun; 1993 Jun; 193(3):814-20. PubMed ID: 8323557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different affinity states of CCK(1) receptors on pancreatic acini and gastric smooth muscle in the rat.
    Kisfalvi K; Rácz G; Zsirka-Klein A; Pelosini I; Scarpignato C; Varga G
    J Physiol Paris; 2001; 95(1-6):391-8. PubMed ID: 11595465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini.
    Pollo DA; Baldassare JJ; Honda T; Henderson PA; Talkad VD; Gardner JD
    Biochim Biophys Acta; 1994 Oct; 1224(1):127-38. PubMed ID: 7524684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats.
    Raybould HE; Taché Y
    Am J Physiol; 1988 Aug; 255(2 Pt 1):G242-6. PubMed ID: 3136661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological dissociation of responses to CCK and gastric loads in rat mechanosensitive vagal afferents.
    Schwartz GJ; McHugh PR; Moran TH
    Am J Physiol; 1994 Jul; 267(1 Pt 2):R303-8. PubMed ID: 8048636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat.
    Mönnikes H; Lauer G; Arnold R
    Brain Res; 1997 Oct; 770(1-2):277-88. PubMed ID: 9372230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
    Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central CGRP inhibits pancreatic enzyme secretion by modulation of vagal parasympathetic outflow.
    Li Y; Jiang YC; Owyang C
    Am J Physiol; 1998 Nov; 275(5):G957-63. PubMed ID: 9815024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a novel cholecystokinin receptor antagonist, FK480, administered intraduodenally, on pancreatic secretion in rats.
    Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S
    Pancreas; 1995 Apr; 10(3):295-300. PubMed ID: 7542771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valsartan, a specific angiotensin II receptor blocker, inhibits pancreatic fluid secretion via vagal afferent pathway in conscious rats.
    Yamamoto M; Wei L; Otani M; Harada M; Otsuki M
    Regul Pept; 2012 Oct; 178(1-3):80-5. PubMed ID: 22796317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.